These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9887276)

  • 21. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders.
    Whiteman P; Handford PA
    Hum Mol Genet; 2003 Apr; 12(7):727-37. PubMed ID: 12651868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ca2+-dependent interface formation in fibrillin-1.
    Jensen SA; Corbett AR; Knott V; Redfield C; Handford PA
    J Biol Chem; 2005 Apr; 280(14):14076-84. PubMed ID: 15649891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1.
    Knott V; Downing AK; Cardy CM; Handford P
    J Mol Biol; 1996 Jan; 255(1):22-7. PubMed ID: 8568869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein.
    Glanville RW; Qian RQ; McClure DW; Maslen CL
    J Biol Chem; 1994 Oct; 269(43):26630-4. PubMed ID: 7929395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the structure, assembly and biological roles of 10-12 nm connective tissue microfibrils from fibrillin-1 studies.
    Jensen SA; Handford PA
    Biochem J; 2016 Apr; 473(7):827-38. PubMed ID: 27026396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias.
    Jensen SA; Iqbal S; Bulsiewicz A; Handford PA
    Hum Mol Genet; 2015 Aug; 24(15):4454-63. PubMed ID: 25979247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome.
    Aoyama T; Tynan K; Dietz HC; Francke U; Furthmayr H
    Hum Mol Genet; 1993 Dec; 2(12):2135-40. PubMed ID: 8111384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.
    Dietz HC; Pyeritz RE
    Hum Mol Genet; 1995; 4 Spec No():1799-809. PubMed ID: 8541880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine model of Marfan syndrome results from an amino acid change (c.3598G > A, p.E1200K) in a calcium-binding epidermal growth factor-like domain of fibrillin-1.
    Singleton AC; Mitchell AL; Byers PH; Potter KA; Pace JM
    Hum Mutat; 2005 Apr; 25(4):348-52. PubMed ID: 15776436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome.
    Liu W; Qian C; Comeau K; Brenn T; Furthmayr H; Francke U
    Hum Mol Genet; 1996 Oct; 5(10):1581-7. PubMed ID: 8894692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of eight mutations in FBN1.
    Halliday D; Hutchinson S; Kettle S; Firth H; Wordsworth P; Handford PA
    Hum Genet; 1999 Dec; 105(6):587-97. PubMed ID: 10647894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization.
    Lee SS; Knott V; Jovanović J; Harlos K; Grimes JM; Choulier L; Mardon HJ; Stuart DI; Handford PA
    Structure; 2004 Apr; 12(4):717-29. PubMed ID: 15062093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marfan syndrome and its disorder in periodontal tissues.
    Suda N; Shiga M; Ganburged G; Moriyama K
    J Exp Zool B Mol Dev Evol; 2009 Jul; 312B(5):503-9. PubMed ID: 19199346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome.
    Reinhardt DP; Ono RN; Notbohm H; Müller PK; Bächinger HP; Sakai LY
    J Biol Chem; 2000 Apr; 275(16):12339-45. PubMed ID: 10766875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events.
    Ramirez F; Dietz HC
    J Cell Physiol; 2007 Nov; 213(2):326-30. PubMed ID: 17708531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fibrillin-Marfan syndrome connection.
    Ramirez F; Pereira L; Zhang H; Lee B
    Bioessays; 1993 Sep; 15(9):589-94. PubMed ID: 8240311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the structure and function of fibrillin-1 by homocysteine suggests a potential pathogenetic mechanism in homocystinuria.
    Hubmacher D; Tiedemann K; Bartels R; Brinckmann J; Vollbrandt T; Bätge B; Notbohm H; Reinhardt DP
    J Biol Chem; 2005 Oct; 280(41):34946-55. PubMed ID: 16096271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly.
    Putnam EA; Zhang H; Ramirez F; Milewicz DM
    Nat Genet; 1995 Dec; 11(4):456-8. PubMed ID: 7493032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.
    Dietz HC; McIntosh I; Sakai LY; Corson GM; Chalberg SC; Pyeritz RE; Francomano CA
    Genomics; 1993 Aug; 17(2):468-75. PubMed ID: 8406497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular basis of Marfan syndrome.
    Maslen CL; Glanville RW
    DNA Cell Biol; 1993 Sep; 12(7):561-72. PubMed ID: 8397814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.